NUTM1 and sarcoma: Since then, CIC::NUTM1 fusions have been identified in at least an additional one CNS patient and twenty sarcoma patients, where the chimera occurs between CIC exons 16, 17, 18, and 20 and NUTM1 exons 2, 3, 4, 5, and 6 (Mangray et al., 2018; Schaefer et al., 2018; Watson et al., 2018; Le Loarer et al., 2019; Biederman et al., 2022; Yang et al., 2022; Ma et al., 2023; Sievers et al., 2023) (Figure 1).